跳至主要内容
临床试验/NCT00432939
NCT00432939已完成不适用

Primary Hyperparathyroidism: Non-classical Manifestations

Columbia University1 个研究点 分布在 1 个国家目标入组 58 人开始时间: 2005年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
58
试验地点
1
主要终点
Structural evidence of increased vascular stiffness or cardiovascular calcification in patients with mild asymptomatic PHPT

研究概览

简要总结

This is a research study to investigate cardiovascular health in people with mild hyperparathyroidism. Previous research has suggested that severe hyperparathyroidism may be associated with abnormalities in the heart and blood vessels. It is unclear whether mild hyperparathyroidism affects cardiovascular health. This study involves the investigation of the heart and blood vessels of people with mild hyperparathyroidism. Various non-invasive laboratory and radiological test to assess cardiovascular and bone health will be done at set intervals over the course of 2 years. It is our hypothesis that patients with primary hyperparathyroidism will have subtle abnormalities in their cardiovascular system. Using state-of-the art techniques that are sufficiently sensitive to detect these subtle abnormalities, we will define cardiovascular features of this disease that have, up to now, eluded clear definition. We expect taht the extent of these findings will be related to the severity of the underlying primary hyperparathyroidism. We further hypothesize that cardiovascular manifestations may regress with successful cure of the hyperparathyroid state.

详细描述

This study involves a total of 4 visits over a 2-year period. A variety of tests to evaluate your cardiovascular and bone health are performed. The details and timing of the tests are explained below.

VISIT #1 During the first visit, a research doctor or assistant explains the procedures in detail and answers questions. Blood is drawn (about 1-2 tablespoons) to confirm the diagnosis of hyperparathyroidism and get baseline blood values.

VISIT #2-4 During the following visits, a variety of procedures are performed to evaluate cardiovascular and bone health. The details of the procedures and when they will be performed are outlined below.

  1. Blood tests are performed at each visit. Approximately 1-2 tablespoons of blood will be drawn at each visit.
  2. A 24-hour urine collection is done 3 times during the 2 year study.
  3. Bone mineral density testing (known as DXA) is performed at baseline, 12 and 24 months after enrollment.
  4. Carotid Ultrasound: At the baseline visit, 12 and 24 months after enrollment, carotid ultrasound is performed.
  5. Echocardiogram: At the baseline visit, 12 and 24 months after enrollment, an echocardiogram is performed.
  6. Endothelial Function: At baseline, 6 and 12 months after enrollment, flow mediated dilation of the brachial artery is performed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary Hyperparathyroidism

排除标准

  • Current use of oral bisphosphonates
  • Addition or change in cholesterol lowering medication
  • impaired renal function (creatinine >2.0 mg/dl)

结局指标

主要结局

Structural evidence of increased vascular stiffness or cardiovascular calcification in patients with mild asymptomatic PHPT

时间窗: 2 years

To determine whether or not there is structural evidence of increased vascular stiffness or cardiovascular calcification in patients with mild asymptomatic PHPT as compared to matched healthy controls, and to determine the reversibility of these manifestations after successful parathyroidectomy

次要结局

  • Evidence of abnormal cardiovascular function in patients with mild asymptomatic PHPT(2 years)
  • Evidence of abnormal cardiovascular structure or function in patients with asymptomatic PHPT who meet NIH Guidelines for Surgery(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Shonni J. Silverberg

Professor of Medicine, Endocrinology

Columbia University

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Effect of Parathyroidectomy on Cardiovascular HealthPrimary Hyperparathyroidism
NCT02989428University of Aarhus69
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium and bone metabolism after successful surgery? – Part IISystematic treatment of patients with neither osteopenia nor osteoporosis after successful surgical treatment for primary hyperparathyroidism with Calcium and Vitamin DHypothesis: Calcium and vitamin D intake after surgery for PHPT protects the bone by keeping PTH in the normal range (less secondary, reactive hyperparathyroidism), prevents hungry bone- syndrome and improve bone-turnover markers (osteoporosis protection).MedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primary
EUCTR2008-001704-23-ATMedizinische Universität Wien, Universitätsklinik für Chirurgie80
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium- and bone metabolism after successful surgery? – Part Systematic treatment of osteopenic and osteoporotic postmenopausal patients after successful surgical treatment for primary hyperparathyroidism with Strontium ranelateOsteopenia or Osteoporosis in postmenopausal womenPrimary hyperparathyroidismMedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primaryMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2008-001703-32-ATMedical University of Vienna60
已完成
不适用
Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized TrialPrimary Hyperparathyroidism
NCT00522028Oslo University Hospital191
已完成
2 期
Studies of Elevated Parathyroid ActivityParathyroid NeoplasmMultiple Endocrine NeoplasiaMEN1HyperparathyroidismHypercalcemia
NCT00001277National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1,553